Diamond Hill Capital Management Inc. Has $10.74 Million Position in Astrana Health, Inc. $ASTH

Diamond Hill Capital Management Inc. increased its stake in Astrana Health, Inc. (NASDAQ:ASTHFree Report) by 19.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 432,726 shares of the company’s stock after purchasing an additional 71,462 shares during the quarter. Diamond Hill Capital Management Inc.’s holdings in Astrana Health were worth $10,736,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ASTH. Signaturefd LLC lifted its holdings in Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after purchasing an additional 388 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after purchasing an additional 871 shares during the last quarter. Strs Ohio acquired a new position in shares of Astrana Health during the 4th quarter worth about $40,000. Covestor Ltd lifted its position in shares of Astrana Health by 210.6% during the 3rd quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after purchasing an additional 2,192 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in shares of Astrana Health by 323.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after purchasing an additional 3,517 shares during the last quarter. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Trading Up 1.3%

Astrana Health stock opened at $37.85 on Friday. The business has a 50 day moving average price of $30.70 and a two-hundred day moving average price of $26.17. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.20. The stock has a market cap of $2.11 billion, a price-to-earnings ratio of 62.05 and a beta of 0.98. Astrana Health, Inc. has a 12 month low of $18.08 and a 12 month high of $39.93.

Astrana Health (NASDAQ:ASTHGet Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, beating the consensus estimate of $0.29 by $0.45. The firm had revenue of $965.10 million during the quarter, compared to analysts’ expectations of $949.21 million. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The company’s revenue for the quarter was up 55.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.42 EPS. As a group, equities analysts forecast that Astrana Health, Inc. will post 1.25 EPS for the current year.

Wall Street Analyst Weigh In

ASTH has been the subject of several research analyst reports. Truist Financial boosted their price objective on Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Barclays boosted their price objective on Astrana Health from $26.00 to $37.00 and gave the stock an “equal weight” rating in a research report on Monday, May 11th. Zacks Research raised Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 11th. BTIG Research boosted their price objective on Astrana Health from $40.00 to $50.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Finally, Needham & Company LLC boosted their price objective on Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $43.14.

Check Out Our Latest Analysis on Astrana Health

About Astrana Health

(Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

See Also

Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTHFree Report).

Institutional Ownership by Quarter for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.